Gelesis Holdings Inc (GLSHQ)

Gelesis Holdings Inc. is a healthcare company whose common stock has been quoted on OTC Markets under the symbol GLSH.Q. The company was described as a commercial-stage biotherapeutics business focused on approaches intended to address obesity and gastrointestinal-related chronic conditions. Its portfolio included PLENITY, an orally administered, non-stimulant, non-systemic aid for weight management, along with development programs such as GS200 for weight loss in prediabetes and type 2 diabetes, GS500 for functional constipation, and the pre-clinical GS300 for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Incorporated in 2006 and based in Boston, Massachusetts, Gelesis Holdings and its affiliates filed a voluntary Chapter 7 liquidation petition on October 30, 2023.

Jump directly to the stock analysis sections supported by the latest available data.